vs

Side-by-side financial comparison of Bit Digital, Inc (BTBT) and RECURSION PHARMACEUTICALS, INC. (RXRX). Click either name above to swap in a different company.

RECURSION PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($35.5M vs $32.3M, roughly 1.1× Bit Digital, Inc). RECURSION PHARMACEUTICALS, INC. runs the higher net margin — -304.2% vs -582.6%, a 278.4% gap on every dollar of revenue. RECURSION PHARMACEUTICALS, INC. produced more free cash flow last quarter ($-47.3M vs $-574.9M).

Digital Equipment Corporation, using the trademark Digital, was a major American company in the computer industry from the 1960s to the 1990s. The company was co-founded by Ken Olsen and Harlan Anderson in 1957. Olsen was president until he was forced to resign in 1992, after the company had gone into precipitous decline.

Recursion Pharmaceuticals is a clinical-stage biotechnology company that combines artificial intelligence and large-scale high-throughput biological experimentation to discover and develop innovative therapies for rare diseases, oncology, inflammatory disorders, and other areas of unmet medical need. It primarily operates in North America and partners with global biopharmaceutical firms to advance its robust therapeutic pipeline.

BTBT vs RXRX — Head-to-Head

Bigger by revenue
RXRX
RXRX
1.1× larger
RXRX
$35.5M
$32.3M
BTBT
Higher net margin
RXRX
RXRX
278.4% more per $
RXRX
-304.2%
-582.6%
BTBT
More free cash flow
RXRX
RXRX
$527.5M more FCF
RXRX
$-47.3M
$-574.9M
BTBT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BTBT
BTBT
RXRX
RXRX
Revenue
$32.3M
$35.5M
Net Profit
$-188.4M
$-108.1M
Gross Margin
59.8%
Operating Margin
-597.0%
-304.8%
Net Margin
-582.6%
-304.2%
Revenue YoY
681.7%
Net Profit YoY
39.6%
EPS (diluted)
$-0.53
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTBT
BTBT
RXRX
RXRX
Q4 25
$32.3M
$35.5M
Q3 25
$30.5M
$5.2M
Q2 25
$25.7M
$19.2M
Q1 25
$25.1M
$14.7M
Q4 24
$4.5M
Q3 24
$26.1M
Q2 24
$14.4M
Q1 24
$13.8M
Net Profit
BTBT
BTBT
RXRX
RXRX
Q4 25
$-188.4M
$-108.1M
Q3 25
$150.9M
$-162.3M
Q2 25
$14.9M
$-171.9M
Q1 25
$-57.7M
$-202.5M
Q4 24
$-178.9M
Q3 24
$-95.8M
Q2 24
$-97.5M
Q1 24
$-91.4M
Gross Margin
BTBT
BTBT
RXRX
RXRX
Q4 25
59.8%
Q3 25
-183.8%
Q2 25
-4.9%
Q1 25
-48.0%
Q4 24
-181.4%
Q3 24
53.7%
Q2 24
36.2%
Q1 24
19.1%
Operating Margin
BTBT
BTBT
RXRX
RXRX
Q4 25
-597.0%
-304.8%
Q3 25
-3327.6%
Q2 25
45.7%
-916.8%
Q1 25
-208.6%
-1297.9%
Q4 24
-4042.4%
Q3 24
-377.1%
Q2 24
-697.4%
Q1 24
-698.4%
Net Margin
BTBT
BTBT
RXRX
RXRX
Q4 25
-582.6%
-304.2%
Q3 25
495.3%
-3135.3%
Q2 25
58.0%
-894.2%
Q1 25
-229.9%
-1373.3%
Q4 24
-3935.5%
Q3 24
-367.5%
Q2 24
-676.6%
Q1 24
-662.4%
EPS (diluted)
BTBT
BTBT
RXRX
RXRX
Q4 25
$-0.53
$-0.17
Q3 25
$0.47
$-0.36
Q2 25
$0.07
$-0.41
Q1 25
$-0.32
$-0.50
Q4 24
$-0.56
Q3 24
$-0.34
Q2 24
$-0.40
Q1 24
$-0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTBT
BTBT
RXRX
RXRX
Cash + ST InvestmentsLiquidity on hand
$118.4M
$743.3M
Total DebtLower is stronger
$9.6M
Stockholders' EquityBook value
$724.0M
$1.1B
Total Assets
$1.2B
$1.5B
Debt / EquityLower = less leverage
0.01×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTBT
BTBT
RXRX
RXRX
Q4 25
$118.4M
$743.3M
Q3 25
$179.1M
$659.8M
Q2 25
$181.2M
$525.1M
Q1 25
$57.6M
$500.5M
Q4 24
$594.4M
Q3 24
$427.6M
Q2 24
$474.3M
Q1 24
$296.3M
Total Debt
BTBT
BTBT
RXRX
RXRX
Q4 25
$9.6M
Q3 25
$11.9M
Q2 25
$14.2M
Q1 25
$16.4M
Q4 24
$19.0M
Q3 24
$20.5M
Q2 24
$22.9M
Q1 24
Stockholders' Equity
BTBT
BTBT
RXRX
RXRX
Q4 25
$724.0M
$1.1B
Q3 25
$906.2M
$1.0B
Q2 25
$633.2M
$919.1M
Q1 25
$417.4M
$933.9M
Q4 24
$1.0B
Q3 24
$524.6M
Q2 24
$584.4M
Q1 24
$401.2M
Total Assets
BTBT
BTBT
RXRX
RXRX
Q4 25
$1.2B
$1.5B
Q3 25
$1.1B
$1.4B
Q2 25
$723.4M
$1.3B
Q1 25
$485.2M
$1.3B
Q4 24
$1.4B
Q3 24
$726.5M
Q2 24
$775.9M
Q1 24
$557.8M
Debt / Equity
BTBT
BTBT
RXRX
RXRX
Q4 25
0.01×
Q3 25
0.01×
Q2 25
0.02×
Q1 25
0.02×
Q4 24
0.02×
Q3 24
0.04×
Q2 24
0.04×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTBT
BTBT
RXRX
RXRX
Operating Cash FlowLast quarter
$-288.9M
$-46.1M
Free Cash FlowOCF − Capex
$-574.9M
$-47.3M
FCF MarginFCF / Revenue
-1778.0%
-133.1%
Capex IntensityCapex / Revenue
884.4%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-943.7M
$-378.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTBT
BTBT
RXRX
RXRX
Q4 25
$-288.9M
$-46.1M
Q3 25
$-240.0M
$-117.4M
Q2 25
$17.7M
$-76.4M
Q1 25
$17.4M
$-132.0M
Q4 24
$-115.4M
Q3 24
$-59.2M
Q2 24
$-82.2M
Q1 24
$-102.3M
Free Cash Flow
BTBT
BTBT
RXRX
RXRX
Q4 25
$-574.9M
$-47.3M
Q3 25
$-256.8M
$-117.6M
Q2 25
$-64.5M
$-79.6M
Q1 25
$-47.6M
$-133.8M
Q4 24
$-116.7M
Q3 24
$-63.8M
Q2 24
$-83.4M
Q1 24
$-109.0M
FCF Margin
BTBT
BTBT
RXRX
RXRX
Q4 25
-1778.0%
-133.1%
Q3 25
-843.1%
-2272.5%
Q2 25
-251.3%
-413.9%
Q1 25
-189.4%
-907.4%
Q4 24
-2567.7%
Q3 24
-244.6%
Q2 24
-578.5%
Q1 24
-789.9%
Capex Intensity
BTBT
BTBT
RXRX
RXRX
Q4 25
884.4%
3.5%
Q3 25
55.4%
4.7%
Q2 25
320.3%
16.4%
Q1 25
258.8%
12.4%
Q4 24
28.6%
Q3 24
17.5%
Q2 24
8.2%
Q1 24
48.2%
Cash Conversion
BTBT
BTBT
RXRX
RXRX
Q4 25
Q3 25
-1.59×
Q2 25
1.19×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BTBT
BTBT

Cloud Services$19.3M60%
Digital Asset Mining$5.5M17%
Colocation Services$3.8M12%
Other$3.7M11%

RXRX
RXRX

Segment breakdown not available.

Related Comparisons